Bacterial isolates and antibiotic susceptibility among women with abnormal vaginal discharge attending the gynecology clinic at a tertiary hospital in southwestern Uganda: a cross-sectional study
-
Published:2023-11-06
Issue:1
Volume:23
Page:
-
ISSN:1472-6874
-
Container-title:BMC Women's Health
-
language:en
-
Short-container-title:BMC Women's Health
Author:
Ahabwe Onesmus Magezi,Kabanda Taseera,Abesiga Lenard,Mugisha Julius,Kayondo Musa,Ngonzi Joseph,Tugume Rodgers,Agaba Collins David,Byamukama Onesmus,Tibaijuka Leevan,Lugobe Henry Mark
Abstract
Abstract
Background
Abnormal vaginal discharge is a common complaint among women of reproductive age, affecting about one- third of all women. In resource-limited settings where access to laboratory services is limited, treatment is usually syndromic. This approach may result in ineffective treatment, with high recurrence rates and a potential of developing antibiotic resistance. This study aimed to determine the bacterial isolates and antibiotic susceptibility among women with an abnormal vaginal discharge attending the gynecology clinic at a tertiary hospital in Southwestern Uganda.
Methods
We conducted a hospital based cross-sectional study among 361 women aged 15–49 years, presenting with abnormal vaginal discharge at the gynecology clinic of Mbarara Regional Referral Hospital from December 2020 to June 2021. Demographic characteristics were collected using a structured questionnaire. We collected cervical and vaginal sterile swabs and subjected them to wet preparation and gram stain. The specimens were cultured for bacterial isolates. Susceptibility testing was performed on samples with bacterial isolates using the Kirby-Bauer disc diffusion method, on the commonly prescribed antibiotics in this setting. We summarized and described the bacterial isolates and antibiotic susceptibility patterns as frequencies and percentages.
Results
We enrolled 361 women with abnormal vaginal discharge. Bacteria were isolated in 29.6% (107/361) of the women, and the commonest isolates included; Staphylococcus aureus 48.6% (52/107), Klebsiella pneumoniae 29.9% (32/107) and Enterococcus faecalis 15% (16/107). Yeast cells were found in 17.7% (64/361) of the women with abnormal vaginal discharge. Cefuroxime (90.7%) and Ciprofloxacin (81.3%) had a high level of sensitivity while high levels of resistance were observed for Doxycycline (86.0%) and Azithromycin (67.0%).
Conclusion
The common bacterial isolates were Staphylococcus aureus, Klebsiella pneumoniae and Enterococcus faecalis. The isolated bacteria were most sensitive to Cefuroxime and Ciprofloxacin but resistant to Doxycycline and Azithromycin. There is need for routine culture and susceptibility testing of women with abnormal vaginal discharge so as to guide treatment, minimize inappropriate antibiotic use and consequently reduce antibiotic resistance.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,General Medicine
Reference22 articles.
1. Organization WH. Simplified approaches for sexually transmitted disease (STD control at the primary health care (PHC level: report of a WHO working group, Geneva, 24–28 September 1984. World Health Organization, 1985.
2. Fonseca TM, Cesar JA, Mendoza-Sassi RA, Schmidt EB. Pathological vaginal discharge among pregnant women: pattern of occurrence and association in a population-based survey. Obstet Gynecol Intern. 2013;2013:590416.
3. Saleh AM, Abdalla HS, Satti AB, Babiker SM, Gasim GI, Adam I. Diagnosis of Trichomonous vaginalis by microscopy, latex agglutination, diamond’s media, and PCR in symptomatic women, Khartoum, Sudan. Diagn Pathol. 2014;9(1):49.
4. Castellano Filho DS, Diniz CG, Silva VL. Bacterial vaginosis: clinical, epidemiologic and microbiological features. HU Revista. 2010;36(3).
5. MoH-Uganda. Uganda Clinical Guidelines: National Guidelines for Management of Common Conditions. 2016. p. 272–6.